Grace Therapeutics, Inc. (GRCE)

Grace Therapeutics, Inc. (GRCE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $41M; returns 1 day +0.8%, 1 week +2.1%, 1 year -38.7%.

Grace Therapeutics, Inc. is a biopharmaceutical company primarily focused on the discovery, development, and commercialization of innovative therapies for rare and orphan diseases.

Groups GRCE belongs to

• Biotechnology
• Rare Diseases
• Biopharmaceutical
• Clinical Stage Biotech
• Pharmaceuticals
• Neuroscience
• Healthcare
• CNS Disorders
• Life Sciences

GRCE financial model: income statement, cash flow and balance sheet